Biological Background of GNG11

GNG11 (G Protein Subunit Gamma 11) is a member of the gamma subunit family of heterotrimeric guanine nucleotide-binding proteins (G proteins). Heterotrimeric G proteins consist of three subunits—alpha (Gα), beta (Gβ), and gamma (Gγ)—and serve as critical molecular switches in cellular signal transduction. Upon activation of G protein-coupled receptors (GPCRs) by extracellular ligands, the Gα subunit exchanges GDP for GTP, leading to dissociation of Gα from the obligate Gβγ dimer. The free Gβγ dimer, including those containing GNG11, can then interact with downstream effectors such as ion channels, adenylyl cyclases, phospholipase C-beta isoforms, and G protein-coupled inwardly rectifying potassium (GIRK) channels.

The human GNG11 gene encodes a relatively small protein that is widely expressed in multiple human tissues. Its gamma subunit role is functionally dependent on forming a stable dimer with Gβ subunits; this Gβγ dimer acts as a functional unit regulating diverse downstream signaling cascades. Research has highlighted GNG11's involvement in processes including angiogenesis, cell proliferation, and potentially aging-associated gene expression programs.

Biochemical Properties and Recombinant Expression

Recombinant Human GNG11 Protein (SKU: rp368015, sourced as absea#PQ-849) is produced using recombinant expression systems to ensure consistency and reproducibility across experimental batches. Gamma subunits of G proteins, including GNG11, are characteristically small hydrophobic proteins that undergo post-translational lipid modification (prenylation at a C-terminal CaaX motif) in native cellular contexts. This modification anchors Gγ to the inner leaflet of the plasma membrane and facilitates Gβγ dimer formation.

When produced as a recombinant protein for research purposes, GNG11 may lack native lipid modifications depending on the expression system employed. Researchers should consult the certificate of analysis (CoA) provided with each lot to confirm purity, formulation buffer composition, concentration, and any relevant quality control data such as SDS-PAGE or functional assay results. Proper handling—including reconstitution in recommended buffers, aliquoting to minimize freeze-thaw cycles, and storage at -80°C—is essential to preserve protein integrity and activity.

Experimental Applications

Recombinant Human GNG11 Protein is suitable for a range of in vitro research applications involving G protein signaling:

• Protein–Protein Interaction Studies: GNG11 can be used in pull-down assays, co-immunoprecipitation experiments, or surface plasmon resonance (SPR) studies to map interactions with Gβ subunits and downstream effector proteins.
• Biochemical and Structural Studies: The recombinant protein can serve as an antigen for antibody validation, as a reference standard in Western blot analyses, or as a component in reconstituted G protein complexes for structural biology investigations.
• Functional Reconstitution Assays: In cell-free systems, recombinant GNG11 may be combined with Gα and Gβ subunits to reconstitute heterotrimeric G protein complexes for GTPase activity assays or effector coupling experiments.
• Drug Discovery Support: As a component of GPCR signaling pathways, GNG11 is relevant to screening campaigns targeting G protein-coupled pathways, including studies on Gβγ-targeted small molecules.

Researchers should optimize protein concentrations and buffer conditions empirically for each specific application, as performance can vary with experimental context.

Handling, Storage, and Quality Considerations

To maintain the integrity and activity of Recombinant Human GNG11 Protein, adhere to the following best-practice guidelines:

• Storage Temperature: Store the protein at -80°C upon receipt. Short-term storage at -20°C may be acceptable depending on formulation; consult the CoA for lot-specific guidance.
• Aliquoting: Upon first thaw, divide the protein into single-use aliquots to avoid repeated freeze-thaw cycles, which can lead to aggregation and loss of activity.
• Reconstitution: If supplied lyophilized, reconstitute in the buffer specified in the CoA. Allow the vial to equilibrate to room temperature before opening, and reconstitute gently without vortexing.
• Carrier Protein: If the protein is supplied at low concentration or in a carrier-protein-free formulation, consider adding BSA (0.1–1%) to stabilize the protein during storage and experimental use.
• Avoid Detergents: Due to the hydrophobic nature of gamma subunits, be cautious with detergent concentrations in working buffers, as excessive detergent may disrupt protein structure.
• Lot-to-Lot Verification: Always verify critical reagent performance with each new lot using orthogonal assays (e.g., SDS-PAGE, functional assay) before use in key experiments.